MIT’s Implantable Nanotech Sensor Monitors for Cancer and Now Heart Attacks, Too | Singularity Hub

MIT’s Implantable Nanotech Sensor Monitors for Cancer and Now Heart Attacks, Too | Singularity Hub: "Heart attacks and cancer account for nearly half of all deaths in the United States – they’re the two biggest killers walking the streets, but MIT isn’t afraid. Michael Cima and his team developed an implantable sensor that uses antibodies attached to nanoparticles to detect cancer related biomarkers. In 2009 Cima showed that he could implant these devices into human tumors in mice and then ‘read’ the cancer growth using MRI. No biopsies need. Over the past few years, Cima and his team have adapted their work to create a very similar device that measures biomarkers related to heart damage."